Completed
Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment
NCT02384577
- Conditions
- Behavior, Health Behavior, Patient Satisfaction, +1 more
- Locations
-
- Teva Investigational Sites Berlin, Germany